Veterinary Medicines

Neo Tylan G250 Premix, 250 mg/g premiscela per alimenti medicamentosi per polli e suini

Authorised
  • Tylosin
Download as PDF

Product identification

Medicine name:
Neo Tylan G250 Premix, 250 mg/g premiscela per alimenti medicamentosi per polli e suini
Active substance:
  • Tylosin
Target species:
  • Chicken (layer hen)
  • Chicken
  • Pig
Route of administration:
  • In-feed use

Product details

Active substance and strength:
  • Tylosin
    250.00
    gram(s)
    /
    1.00
    kilogram(s)
Pharmaceutical form:
  • Premix for medicated feeding stuff
Withdrawal period by route of administration:
  • In-feed use
    • Chicken (layer hen)
      • Egg
        0
        day
    • Chicken
      • Meat
        3
        day
    • Pig
      • Meat
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ups Healthcare Italia S.r.l.
  • Eli Lilly And Company Limited
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 102890
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 27/05/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."